JPRN-jRCTs042210092已完成未知
Comparison of Silicone Hydrogel Daily Disposable Multifocal Contact Lens (MyDay daily disposable Multifocal) and Habitually Worn Soft Contact Lenses in Presbyopic Patients
Kodama Yuji0 个研究点目标入组 109 人开始时间: 2021年10月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 109
研究概览
简要总结
The study lens was superior in the following endpoints. (1) The overall evaluation score for near vision of the study lens was superior to that of the previous lenses. (2) As a result of the relative comparison between the study lens and the previous lens, the study lens was found to be superior in overall comparison of lenses by VAS, wearing feeling, distance/mid-distance/near vision, and overall vision.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 42age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1) He/she is at least 42 years of age when giving his/her informed consent
- •2) He/she is presbyopia
- •3) He/she habitually wears any of the following SCLs for at least 8 hours a day, 5 days a week until he/she gave consent
- •- Daily disposable sphere soft contact lenses (Any brand)
- •- Multifocal silicone hydrogel lenses Dailies Total 1 MF
- •- Multifocal hydrogel lenses Proclear 1 Day MF
- •4) He/she can achieve a corrected distance visual acuity of at least 0.9 (decimal visual acuity) in each eye through refractive correction with spherocylindrical lenses
- •5) He/she has sphere power of +3.00~-8.00 when taking into account vertex distance
- •6) He/she has refractive astigmatism (cylindrical power) no higher than 1.00D from a manifest refraction
- •7) He/she requires a reading addition of at least +0.75D and no more than +2.50D from a manifest refraction
- •8) He/she is willing to undergo a medical examination on the specified examination date
- •9) He/she understood the information sheet and was able to give his/her voluntary written consent.
排除标准
- •1) He/she has worn hard contact lenses within 30 days before giving his/her consent
- •2) He/she has undergone refractive error surgery
- •3) He/she who has had an aphakic intraocular or intraocular lens implanted in his/her eye(s)
- •4) He/she is evaluated by slit lamp to have anterior ocular complications evaluated to be 3 or higher on the Efron Grading Scales
- •5) He/she is not satisfied with his/her visual quality with a single adjustment to sphere power of study lenses at baseline
- •6) He/she who has the following ophthalmic diseases
- •- Acute and subacute inflammation of the anterior chamber of the eye
- •- Ocular infection
- •- Decreased corneal sensitivity
- •- Eyelid abnormalities
- •7) He/she who has dry-eye symptoms and lacrimal apparatus disease to an extent that may cause issues in wearing lenses
- •8) He/she who has allergic diseases that may impact wearing lenses
- •9) He/she who usually resides in a dry environment
- •10) He/she who resides in an environment where dust and chemicals, etc. easily enter the eyes
- •11) He/she who is unable to follow the physician's instructions
- •12) He/she who is unable to use the lenses in an appropriate manner
- •13) He/she who is unable to follow lens care regimen
- •14) She self-reports as pregnant, lactating, or taking oral contraceptives
- •15) He/she who is participating in other clinical trials or studies
- •16) Anyone who is determined by the Co-Principal Investigators or others to be ineligible for this study.
研究者
相似试验
已完成
不适用
Performance Evaluation of Daily Disposable Contact Lenses in Habitual Lens Wearers Who Use Digital Devices FrequentlyMyopiaNCT05805150Coopervision, Inc.69
已完成
不适用
Comparison of a Silicone Hydrogel Daily Disposable Multifocal Contact Lens to a Marketed ProductVisual AcuityNCT05258149Johnson & Johnson Vision Care, Inc.143
已完成
不适用
Performance Evaluation of a New Daily Disposable Silicone Hydrogel LensMyopiaNCT01371552CIBA VISION119
已完成
不适用
Clinical Comparison of Silicone Hydrogel and HEMA-based Daily Disposable Contact LensesMyopiaNCT01362907CIBA VISION40
已完成
不适用
Clinical Evaluation of Two Silicone Hydrogel Daily Disposable Contact LensesVision DisordersNCT02595502Johnson & Johnson Vision Care, Inc.286